The Year Putting Computers in People's Brains Stops Being Science Fiction

When motivation is lacking, jumping into heavy routines is the fastest way to burn out. That’s why millions of people are turning to walking as the foundation of their fitness journey.

Walking lets you enjoy the outdoors, clear your head, and practice mindfulness. It’s simple, sustainable, and can support lasting weight loss if you know how much you need. The “10,000 steps a day” rule is outdated; everyone’s lifestyle is different.

With Simple, you’ll get access to habit-based coaching that’s helped users lose over 18 million pounds. Take the quiz to discover your personalized walking target.

Take the Quiz

This one will sound dramatic until you check the dates. Brain implants that let people control computers with their thoughts are going from one patient at a time to high-volume production in 2026. The surgery is becoming nearly fully automated. Apple has built a protocol that lets these implants control iPads. Three different companies are racing to dominate a market that did not commercially exist twelve months ago. And while most of the tech press is focused on AI chatbots, the most consequential human-computer interface revolution since the smartphone is happening inside actual human skulls. Today we walk through where we actually are, what is real and what is hype, and what the next five years probably look like. Strap in.

Start with the most consequential announcement most people missed. On December 31, 2025, Elon Musk posted to X that "Neuralink will start high-volume production of brain-computer interface devices and move to a streamlined, almost entirely automated surgical procedure in 2026. Device threads will go through the dura, without the need to remove it. This is a big deal." The Takeout

Translate that out of Musk-speak and what you have is a company that has, until now, implanted brain chips in a small handful of patients on a one-at-a-time basis, declaring its intention to mass-manufacture them this year. As of September 2025, a total of 12 people worldwide with severe paralysis had received Neuralink implants. These patients range from a paralyzed man with amyotrophic lateral sclerosis to quadriplegics with spinal cord injuries, all of whom now use brain-computer interfaces to communicate, type, and control digital tools using thought alone. The plan is to move from twelve patients to far higher numbers within the year. 40 Aprons

The technical specifics are worth understanding because they put the news in context. Neuralink's N1 implant uses a robotic surgeon to insert 1,024 ultra-thin electrode threads into the motor cortex of the brain. The device reads electrical signals generated when a patient thinks about movement, then translates those signals into cursor control on a computer screen. "The Link" is the size of a quarter, about 23 millimeters in diameter and around 8 millimeters thick. It reads electrical signals from neurons and translates them into digital commands. The ultimate goal is to allow users to control devices with their minds, restoring lost functionality through the device. The Kitchn40 Aprons

And as of May 2026, Neuralink also announced its next-generation surgical robot. According to Musk's update highlighted on May 7, 2026, the company is developing a surgical robot designed to access any part of the brain with high precision. Neuralink says the long-term goal is to create a "generalised neural interface" that could eventually help address a wide range of neurological conditions originating in the brain. The robot uses advanced cameras and sensors to navigate the brain's natural movements from breathing and heartbeat, minimizing bleeding or scarring during implantation. The TakeoutThe Takeout

Fierce Biotech on Neuralink's production timeline: https://www.fiercebiotech.com/medtech/elon-musks-neuralink-kickstart-high-volume-production-brain-computer-interface-devices

The Debrief on what high-volume BCI production actually means: https://thedebrief.org/neuralink-set-to-launch-high-volume-brain-implant-production-as-competitors-weigh-in/

The temptation with brain interface stories is to either dismiss them as hype or treat them as magic. The actual patient experience is more grounded and more astonishing than either framing. Let me give you specifics.

The first person to have the Neuralink device implanted was 29-year-old quadriplegic patient Noland Arbaugh. A diving accident had dislocated the vertebrae in his neck, leaving him paralyzed from the shoulders down for years. After receiving the Neuralink implant in January 2025, he has since used the device to play video games, online chess and other activities. Arbaugh's reaction was "I was not expecting it to be as good as it is. I think there were moments when I realized, like, 'Oh, this is a much bigger deal than I thought it was.'" 40 Aprons40 Aprons

A more recent example is even more striking. Brad Smith, an Arizona husband and father with ALS, became the third person to receive a Neuralink implant. Completely paralyzed and reliant on a ventilator to breathe, he created a video using the brain-computer interface to control the mouse on his MacBook Pro and posted it to X. "I am typing this with my brain. It is my primary communication," Smith wrote. A man who could not move at all, restoring his ability to communicate with the world by thinking. The Takeout

These are not edge cases or single-patient anecdotes. Synchron, Neuralink's main competitor backed by investors that include Bill Gates and Jeff Bezos, has implanted its Stentrode device in over 50 patients with paralysis, enabling them to control computers and communicate using only their thoughts. Paradromics has demonstrated clinical trials where patients with locked-in syndrome communicate at speeds approaching natural speech. This is a real technology, in real human bodies, doing real things. Gadget Flow

The competitive landscape is now broad. Neuralink, Synchron, Blackrock Neurotech, Precision Neuroscience, and Paradromics are all advancing. All have received the FDA's breakthrough device designation, which accelerates the development and review process for serious conditions. What was a single Elon Musk project two years ago is now a multi-company industry with real clinical data and real momentum. Engadget

YourStory on Neuralink's surgical robot expansion: https://yourstory.com/2026/05/neuralink-surgical-robot-brain-interface-2026

Engadget's ongoing coverage of Synchron and BCI competitors: https://www.engadget.com/tag/synchron

Here is the story behind the story. In May 2025, Apple quietly announced something that should have been front-page tech news but barely registered. Apple announced a BCI Human Interface Device input protocol that allows brain-computer interfaces to interact with Apple products. Subsequently, Synchron demonstrated its BCI's ability to control an iPad in August 2025. Engadget

Pause and let that land. Apple, the company that defined the smartphone interaction model and the touchscreen revolution, has officially designated brain-computer interfaces as a first-class input method for its devices. The same operating system that handles mice, keyboards, touchscreens, and game controllers now handles signals coming directly out of a human brain. The protocol is open enough that any BCI manufacturer that meets the spec can integrate with iPhones, iPads, and Macs.

The strategic implication is enormous. The single biggest constraint on BCI adoption has not been the technology itself. It has been the question of what the device controls. Until Apple's announcement, a BCI manufacturer needed to either build their own software ecosystem from scratch or hope that consumer device makers would eventually support them. Apple's move turned the iPhone and iPad into the default targets. A paralyzed patient with a BCI implant can now use the same apps everyone else uses, on the same hardware, with the same updates. That is the difference between a niche medical device and a mass-market platform.

There is a quieter consequence worth flagging. Apple does not typically build new input protocols speculatively. They built one for touchscreens because they knew iPhone was coming. They built one for force-touch because they were shipping it. The fact that they built one for BCIs suggests that, at the executive level, Apple sees this technology as part of the medium-term product roadmap rather than a long-term science project. Whether they ever ship their own BCI is a separate question, but they have clearly decided not to be left out of the input layer.

Clinical Trials Arena on the broader BCI landscape: https://www.clinicaltrialsarena.com/analyst-comment/brain-computer-interfaces-closer/

STAT on the tension inside Neuralink's mission: https://www.statnews.com/2026/01/05/neuralink-brain-computer-interface-medical-device-vs-transhumanism/

Before this gets too breathless, let me give you the unvarnished version of where the technology actually is. Brain interfaces work. They are real. They have genuinely transformed lives for the patients who have received them. They are also, in 2026, still hard, expensive, risky, and limited.

The hard parts. Several months after Arbaugh's implant, several electrode threads retracted from their optimal positions in the brain, reducing the number of electrodes capturing useful signals. Neuralink adapted the device's software to extract more information from the remaining electrodes, partially compensating for the hardware issue. Arbaugh himself, asked about long-term effects, said "Maybe it is doing something terribly wrong to my brain. We've been doing checkups pretty regularly, and we haven't seen any adverse effects. But it's just one of those things, like, you don't know until all the data comes out long term." The honesty there matters. These are early patients in early studies, and ten-year safety data simply does not exist yet because the technology has not been in human bodies for ten years. The Kitchn40 Aprons

The expensive parts. BCI implantation involves brain surgery, which carries inherent risks even when performed by automated surgical robots. The implants themselves cost in the high tens of thousands of dollars at current production volumes, and the per-patient cost of clinical trials runs higher than that. The road to "BCIs are routinely covered by health insurance" is realistically a five-to-ten-year regulatory and economic process, not something that happens because production scales up this year.

The limited parts. Current BCIs do one thing well: they read motor intent from the motor cortex and translate it into cursor movements or simple selections. They do not read your thoughts, your memories, your emotions, or your preferences. They do not transmit information into your brain (with the exception of some early vision-restoration research like Neuralink's Blindsight project). They are extraordinarily impressive at what they do, but what they do is narrow.

Where this is all going. Limited commercial availability for severely disabled patients is expected by 2028 to 2030. Broader availability for less severe conditions could follow in the 2030s. Consumer-grade BCIs for healthy individuals are not expected within the current decade. If you are imagining a future where you walk into the Apple Store and walk out with a brain chip, that is not 2026. That is not even 2030. The realistic near-term future is mass restoration of function for hundreds of thousands of paralyzed patients. The further future, the elective consumer BCI, remains genuinely uncertain in both timing and ethics. The Kitchn

Even if you will never have a brain chip and do not know anyone who will, this story matters for several reasons that have nothing to do with science fiction.

First, it tells you where serious money is finally going to land in the next wave of medical technology. Brain interface companies are now backed by Bezos, Gates, Musk, and the deepest pools of patient venture capital. That money will produce treatments for conditions that have been considered untreatable for centuries, including paralysis, severe ALS, certain forms of blindness, and possibly some psychiatric conditions. If anyone you love is affected by these conditions, the 2026 to 2032 window is the most hopeful one in human history.

Second, it raises real questions about data and privacy that society has not figured out yet. The same protocol that lets a paralyzed person control an iPad with their thoughts also creates a literal direct readout of brain activity, sent over the air to a company's servers. Data privacy for neural signals, consent protocols for patients with severe communication impairments, equitable access to expensive implanted technology, and the long-term implications of commercial companies having access to brain data all require careful governance frameworks. Those frameworks do not yet exist in any meaningful regulatory form. They will be written over the next five years, mostly in the wake of incidents nobody has predicted yet. The Kitchn

Third, the fundamental computer-human interface that has defined the last thirty years (the screen, the mouse, the keyboard, the touchscreen) is genuinely starting to get its first credible alternative. We do not know if the brain interface ever leaves the medical context. We do know that the early signals are real, and that for a small but growing number of human beings, the answer to "what do you use to control your computer" is now "my mind." That is a sentence that did not exist outside science fiction five years ago. The fact that it is now a clinical reality is the actual headline.

We will keep tracking this and bring you the next chapter as it lands. Stay thoughtful out there.